National Science Foundation — 2024 Investments
2 investments dated 2024 · listed companies and verified rows first · show all
EnduraTx develops small-molecule medicines that form permanent covalent bonds with disease-causing RNA to block production of proteins that cannot be drugged at the protein level, targeting conditions such as certain cancers and neurodegenerative diseases.
AI & Machine LearningBiotechDeep Tech
Co-investorsMoxxie VenturesSciFoundersScribble VenturesTrue VenturesCalm Ventures
TestParty is an automated accessibility platform that scans and fixes source code to make websites, eCommerce sites, and media assets compliant with accessibility regulations like WCAG and ADA.
AI & Machine LearningDeveloper ToolsSaaS
Co-investorsThe MBA FundUrban InnovationGaingelsHarlem CapitalHarlem Capital PartnersSoma Capital
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.






__Twitter.png)
